The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer

Journal of Pathology

Volumn 180, Issue 1, 1996, Pages 38-43

  Tomlinson, I P M ^a   Nicolai, H ^b   Solomon, E ^b   Boomer, W F ^a  

^a Cancer Genetics Laboratory   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

11q; Allele loss; Breast cancer; Loss of heterozygosity

Indexed keywords

PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; CHROMOSOME 11Q; FEMALE; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; ALLELES; BREAST NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; DNA, NEOPLASM; FEMALE; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; RECEPTORS, PROGESTERONE;

EID: 0029987371     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199609)180:1<38::AID-PATH638>3.0.CO;2-C     Document Type: Article

References (25)

1. Stickland JE, Tomlinson IPM, Lee ASG, Evans MF, McGee JO'D. Allelic loss on chromosome 11q is a frequent event in breast cancer. Br J Cancer 1992; 66: (Suppl. xvii): 3.
2. Tomlinson IPM, Stickland JE, Lee AS-G, et al. Frequent loss of heterozygosity on chromosome 11q in breast cancer. J Clin Pathol 1995; 48: 424-428.
3. Hampton GM, Winqvist R, Mannermaa A, et al. Loss of heterozygosity in human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 1994; 54: 4586-4589.
4. Carter SL, Negrini M, Baffa R, et al. Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 1994; 54: 6270-6274.
5. Savitsky K, Barshira A, Gilad S, et al. A single ataxia-telangiectasia gene with a product similar to pi-3 kinase. Science 1995; 268: 1749-1753.
6. Pippard EE, Hall AJ, Barker DJP, Bridges BA. Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 1988; 48: 2929-2932.
7. Kobayashi H, Espionsa R, Fernald AA, et al. Analysis of deletions of the long arm of chromosome 11 in haematologic malignancies with fluorescent in situ hybridisation. Genes Chrom Cancer 1993; 8: 246-252.
8. Keldysh PL, Dragani TA, Fleischman EW, et al. 11q deletions in human colorectal carcinomas: cytogenetics and restriction fragment length polymorphism analysis. Genes Chrom Cancer 1993; 6: 45-50.
9. Gustafson CE, Young J, Leggett B, Searle J, Chevenix-Trench G. Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours. Br J Cancer 1994; 70: 395-397.
10. Tomlinson IPM, Gammack AJ, Stickland JE, et al. Loss of heterozygosity in malignant melanoma at loci on chromosomes 11 and 17 implicated in the pathogenesis of other cancers. Genes Chrom Cancer 1993; 7: 169-172.
11. Walker GJ, Palmer JM, Walters MK, Hayward NK. A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chrom Cancer 1995; 12: 134-141.
12. Healy E, Rehman I, Angus B, Rees JL. Loss of heterozygosity in sporadic cutaneous melanoma. Genes Chrom Cancer 1995; 12: 152-156.
13. Foulkes WD, Campbell IG, Stamp GWH, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer 1993; 67: 268-273.
14. Hampton GM, Penny LA, Baergen RN, et al. Loss of heterozygosity in cervical carcinoma: sub-chromosomal location of a putative tumour suppressor gene at 11q22-q24. Proc Natl Acad Sci USA 1994; 91: 6953-6957.
15. Bethwaite PB, Koreth J, Herrington CS, McGee JO'D. Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma. Br J Cancer 1995; 71: 814-818.
16. Gyapay G, Morissette J, Vignal A, et al. The 1993-94 Genethon human genetic-linkage map. Nature Genet 1994; 7: 246-339.
17. Warnich L, Groenewald I, Theart L, Relief AE. Highly informative dinucleotide repeat polymorphism at the D11S29 locus on chromosome 11q23. Hum Genet 1992; 89: 357-359.
18. Telatar M, Concannon P, Tolun A. Dinucleotide repeat polymorphism at the NCAM locus. Hum Genet 1994; 94: 109.
19. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993; 53: 5849-5852.
20. Huang THM, Yeh PLH, Maritn MB, et al. Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma. Diagn Mol Pathol 1995; 4: 66-72.
21. Patel U, Grundfestbroniatowski S, Gupta M, Banerjee S. Microsatellite instabilities at 5 chromosomes in primary breast tumours. Oncogene 1995; 9: 3695-3700.
22. Nicholson RI, McClelland RA, Gee JMW. Steroid hormone receptors and their clinical significance in cancer. J Clin Pathol 1995; 48: 890-895.
23. Fearon ER, Cho KR, Nogro JM, et al. Identification of a chromosome-18q gene that is altered in colorectal cancers. Science 1990; 247: 49-56.
24. Smith SA, Easton DF, Evans DGR, Ponder BAJ. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet 1992; 2: 128-131.
25. Vorechovsky I, Rasio D, Luo LP, et al. The ATM gene and susceptibility to breast cancer-analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 1996; 56: 2726-2732.